Skin & hair

The Isotretinoin Journey, Month by Month

Save

Starting isotretinoin means signing on for months, not weeks, and the ride has a predictable rhythm — a dry, sometimes bumpy start, a turning point in the middle, and a quieter, clearer finish. Knowing roughly what each stretch brings makes the hard early weeks easier to sit through. This is the arc of a full course.

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

Before you start: labs, iPLEDGE, and expectations

Before the first tablet, two things happen: your clinician confirms isotretinoin is the right choice, and you enroll in the safety program that runs alongside it. Isotretinoin is strongly recommended for severe, scarring, or stubborn acne that has not cleared with other treatment 1, so a course usually begins after topical care, and often oral antibiotics or hormonal options, have already been tried. Understanding who isotretinoin is actually for — people whose acne is deep, persistent, or already scarring, not a mild breakout — sets honest expectations from day one.

The pre-course setup. You will typically have baseline bloodwork and, for anyone who can become pregnant, a pregnancy test, because isotretinoin is dispensed only through the FDA's iPLEDGE program, which requires registration and pregnancy prevention for those who can conceive 2. This is also the moment to ask your questions: how long your planned course is, what monitoring to expect, and how to handle the dryness that is coming. The course is a defined stretch of months, not an open-ended medication — knowing that reframes the whole experience.

Mindset matters here more than people expect. The first weeks are the hardest, the payoff arrives later, and the people who do best are usually the ones who knew the arc before they started rather than discovering it in a panic partway through.

The first weeks: dryness arrives, and sometimes a flare

The first few weeks are defined by dryness. Chapped lips are almost always the first sign the drug is working — they arrive early and stay for the whole course, along with drier skin, drier eyes, and sometimes a dry, tender nose. A Cochrane review lists these mucocutaneous effects as the near-universal, reversible cost of an effective drug 3, which is why lip balm becomes a constant companion from the very first days.

The early flare. Some people find their acne gets worse before it gets better in the opening weeks — the so-called isotretinoin purge, or initial flare. It does not happen to everyone, it is usually temporary, and it is not a sign the drug is failing; it is often the sign it has started to work. It can be disheartening precisely because it lands right when you were hoping for improvement, so it helps to expect the possibility rather than be blindsided by it.

Settling into a routine. This is the stretch where the daily habits form: a gentle cleanser, a heavy moisturizer, balm within reach, eye drops if needed, and sun protection, because the skin becomes more sun-sensitive. None of it is complicated, but starting it on day one rather than week three saves a lot of discomfort. The dryness is manageable; it is mostly a matter of getting ahead of it instead of chasing it.

The middle months: the turning point

Somewhere in the early-to-middle stretch, most people hit the turning point — the acne visibly slows, fewer new spots appear, and the skin starts to look calmer even while the dryness continues. This is the reward the hard first weeks were buying, and it is usually the moment people stop dreading the course and start trusting it.

Monthly check-ins. The course runs on a monthly rhythm because of both monitoring and the safety program. Clinicians generally repeat bloodwork during the course, since isotretinoin can raise lipid and liver values, and isotretinoin blood tests are how that is kept in view. For anyone who can become pregnant, each cycle also includes the iPLEDGE pregnancy test and confirmation before the next supply is released 2. Keeping these appointments on schedule is what prevents a gap in treatment.

Aches and other effects. As the months go on, some people notice muscle and joint aches or back stiffness — one of the other adverse effects the drug can cause beyond the skin 3. It tends to be mild and manageable, but isotretinoin joint pain is worth mentioning to your clinician, especially if you are active, so it can be watched rather than quietly pushed through. Naming it early usually makes it easier to manage than ignoring it and hoping it passes.

The later months: clearing and finishing the course

In the later months, the goal shifts from clearing to finishing. By this stage many people are largely clear, and the real work becomes completing the full course your clinician planned rather than stopping the moment the skin looks good. Isotretinoin is used as a defined course precisely because its benefit is tied to seeing it through, and it is strongly recommended for exactly the severe or scarring acne where quitting early risks losing hard-won ground 1.

Why finishing matters. Stopping the underlying acne is also how you stop the damage. Deep, inflammatory acne is what leaves pitted or raised scars, and those scars are far harder to treat later than the acne is to clear now 4. Completing the course is often the difference between calming the acne for good and letting it keep marking the skin. This is a common place for motivation to dip — the skin looks great, the dryness is tiring — which is exactly why the finish line is worth naming out loud in advance.

The length of a course varies from person to person, and isotretinoin course duration is one of the first things worth clarifying with your clinician, so the end of the journey is a shared plan rather than a surprise you stumble into.

The temptation to stop early. The hardest motivational stretch is often these later months, when the skin already looks clear and the daily dryness has worn thin. Stopping there can leave the job unfinished, and it is one of the more common reasons acne comes back sooner than it needed to. The steadier move is to hold the plan you and your clinician set at the start, and to treat 'my skin looks great' as a milestone within the course rather than the signal to end it.

Managing side effects across the course

Across the whole course, a handful of side effects recur, and knowing how they behave keeps them from feeling alarming. Dryness is the constant — lips, skin, eyes — and it is treated rather than endured, easing once the drug stops 3. Sun sensitivity means daily sun protection is not optional. Muscle and joint aches come and go for some people 3. And mood deserves honest attention: any new low mood, hopelessness, or thought of self-harm is worth raising promptly, not waiting for the next scheduled visit.

The IBD fear, in context. One of the most common worries is that isotretinoin causes inflammatory bowel disease. A large, recent global study did not find a clinically meaningful increase in that risk 5. That does not erase individual history, but it reframes a fear that has kept many people from finishing — or even starting — a course that could have helped them.

Exercise and daily life. Most people continue their normal routines, though intense lifting can aggravate the joint and muscle aches for some, so it is reasonable to scale back if the aches flare and to mention it to your clinician. The theme across all of this is the same: these effects are known, watched, and temporary, which is what makes a demanding course tolerable rather than frightening.

Small habits that help. A few unglamorous habits carry most of the day-to-day comfort: balm and moisturizer kept everywhere you spend time, eye drops within reach, water nearby, and sun protection made automatic before you leave the house. None of it changes the drug's underlying work, but it changes how the months feel, turning the dryness from a daily surprise into a managed background hum you stop noticing.

After the last dose: what settling looks like

The last tablet is not quite the end of the story, in the best way. Skin usually keeps improving for weeks after the course finishes, as the oil glands stay quieted and lingering spots resolve. The dryness fades over the following weeks, and the version of your skin you should judge the course by is really the one a month or two later, not the day you stop.

Marks and scars. Red or brown marks left behind often fade on their own with time and sun protection. True scars — pitted or raised — are addressed later, once the skin is stable, and a range of options from resurfacing to microneedling can help, usually working best in combination 4. There is no rush; scar treatment is a calmer conversation once the acne itself has settled.

Keeping it clear. Many people stay clear for a long time, but acne can return, and isotretinoin relapse is common enough that it is worth planning for rather than treating as a failure. Some clinicians start a maintenance topical after the course — a fixed adapalene and benzoyl peroxide gel, for instance, is more effective than either alone and does not drive antibiotic resistance 6 — to help hold the gains. If acne does come back meaningfully, options include another course, sometimes a low-dose isotretinoin approach, or a hormonal route for those it suits. The end of a course is the right time to agree on a plan for what comes next, so a relapse is met with a strategy rather than a scramble.

Everyone's timeline is a little different

The arc described here is a composite, not a promise. Some people flare hard early and others never do; some are clear by the middle months and some need the full stretch; dryness is heavy for one person and mild for the next. The rhythm — dry start, mid-course turn, clearer finish, continued settling afterward — holds for most, but the exact weeks are yours alone, which is why comparing your course to someone else's rarely helps.

What stays constant is the value of knowing the shape in advance. The course is demanding in its early weeks and generous by its end, and the people who move through it best are the ones who treated it as a planned journey with a known middle and a known finish. They checked in on schedule, kept ahead of the dryness, and asked their questions out loud instead of carrying the worry alone. Seen that way, the month-by-month journey is less an ordeal to survive than a defined stretch to walk through, one predictable phase at a time.

Common questions

A course usually runs several months, but the exact length is set by your clinician and varies from person to person. It is planned as a defined stretch rather than an open-ended medication, and the benefit is tied to completing it. Clarifying your expected course length at the start is worthwhile, so the finish is a shared plan instead of a surprise you reach mid-treatment.

No. Some people find their acne worsens in the first weeks before it improves, while others never flare at all. When it happens, the purge is usually temporary and is not a sign the drug is failing — often the opposite. Because it can land right when you were hoping for improvement, it helps to expect the possibility so it does not feel like a setback.

Most people hit a turning point somewhere in the early-to-middle months, when new spots slow and the skin looks calmer. Steady clearing builds from there, and the skin often keeps improving for weeks after the last dose. The early weeks are the hardest and the payoff comes later, which is why patience through the dry, bumpy start tends to be rewarded.

Monitoring runs on a regular schedule set by your clinician, because isotretinoin can raise lipid and liver values that are worth keeping in view. For anyone who can become pregnant, each cycle also includes an iPLEDGE pregnancy test before the next supply is released. The exact frequency of bloodwork is a clinical decision, so your prescriber is the right source for your specific monitoring plan.

Many people stay clear for a long time, but relapse does happen for some, and it is not a failure when it does. If acne returns meaningfully, options include another course, sometimes a lower-dose approach, or a hormonal route for those it suits. Because it is not fully predictable, the end of a course is a good time to agree on a plan for what happens next.

Most people keep up their usual activity. Some notice muscle and joint aches that intense lifting can aggravate, so scaling back during a flare and mentioning it to your clinician is reasonable. There is no blanket rule against exercise, but listening to the aches and adjusting — rather than pushing hard through them — tends to make the course more comfortable across its months.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

When to call during your isotretinoin course

  • New or worsening depression, mood changes, or thoughts of self-harm
  • Severe stomach pain, ongoing diarrhea, or rectal bleeding
  • A severe or persistent headache with blurred or double vision, nausea, or vomiting
  • A missed period or possible pregnancy while taking isotretinoin

If you have thoughts of harming yourself, call or text 988 (the Suicide and Crisis Lifeline) any time. A possible pregnancy while on isotretinoin is an urgent call to your prescriber, not something to wait on.

This article describes a typical course in general terms and is educational, not medical advice. Your timeline, monitoring, and any medication decisions are set by the clinician managing your treatment, who should be your source for anything specific to you.

References

  1. 1.Reynolds RV, Yeung H, Cheng CE, et al. (2024). Guidelines of care for the management of acne vulgaris. Journal of the American Academy of Dermatology. PMID 38300170Oral isotretinoin is strongly recommended for severe, scarring, or refractory acne reached after topical and other options, supporting who a course is for and the value of completing it.
  2. 2.U.S. Food and Drug Administration (2023). iPLEDGE Risk Evaluation and Mitigation Strategy (REMS). U.S. Food and Drug Administration. linkIsotretinoin is teratogenic and is dispensed only through the iPLEDGE REMS, which requires registration and, for those who can become pregnant, pregnancy testing and contraception each cycle.
  3. 3.Costa CS, Bagatin E, Martimbianco ALC, et al. (2018). Oral isotretinoin for acne. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD009435.pub2Isotretinoin is effective, with near-universal, reversible mucocutaneous dryness (lips, skin, eyes) and other adverse effects that recur across the course.
  4. 4.Boen M, Jacob C (2024). Atrophic Postacne Scar Treatment: Narrative Review. JMIR Dermatology. linkDeep inflammatory acne can leave atrophic scars that are hard to treat later, and post-acne scar treatment works best with combined modalities once the skin is stable, supporting the value of finishing the course and later scar care.
  5. 5.Tan NKW, Tang A, Lim RK, et al. (2023). Isotretinoin and the risk of inflammatory bowel disease and irritable bowel syndrome: A large-scale global study. Journal of the American Academy of Dermatology. PMID 36529376Large-scale global data do not show a clinically meaningful increase in inflammatory bowel disease risk associated with isotretinoin.
  6. 6.McKeage K, Keating GM (2011). Adapalene 0.1%/benzoyl peroxide 2.5% gel: a review of its use in the treatment of acne vulgaris in patients aged ≥ 12 years. American Journal of Clinical Dermatology. PMID 21967116A fixed-dose adapalene/benzoyl peroxide gel is more effective than either component alone and does not promote antibiotic resistance, supporting topical maintenance after an isotretinoin course.

6 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — citations link their sources. Editorial policy